Primetime TV Host Jeffrey Hayzlett Makes Pulmonary Hypertension Association His Cause, will Emcee Annual O2 breathe at Gala in NYC, November 6
Event honors award-winner singer Chloe Temtchine, Managing Partner/Co-Founder Vanterra Capital LLC Shad Azimi, and Evelyn Horn, MD Director of Heart Failure and Pulmonary Hypertension, Weill Cornell Medical Center
The Pulmonary Hypertension Association’s 2nd Annual O2 breathe Gala will take place on Thursday, November 6, at The Lighthouse at Pier 61 in New York City. Moved by the story of event honoree Chloe Temtchine, Bloomberg TV contributing editor and host of MYOB on C-Suite TV, Jeffrey Hayzlett, will be the evening’s master of ceremonies. Hayzlett will be joined on stage by another media notable, Rolonda Watts, who’s new Celebrity Crowdfunding Magazine, will also raise awareness and support for PHA.
“Pulmonary hypertension patient and gifted singer/songwriter, Chloe Temtchine, will be honored with the Be Brave Award. Shad Azimi, Managing Partner/Cofounder Vanterra Capital LLC, will receive The O2 breathe Award. The Robyn J. Barst Award will go to Evelyn Horn, MD, Director of Heart Failure and Pulmonary Hypertension at Weill Cornell,” said Gina Parziale, Executive Director of the Greater New York/ Philadelphia Chapter of PHA. “We are so grateful to Jeffrey Hayzlett for donating his time to support the event and the cause.”
“Chloe Temtchine’s story is so moving, and her talent in the face of all obstacles is nothing short of amazing. After listening to Chloe's story and the stories of countless others, the work the Pulmonary Hypertension Association has been doing has taken a new meaning for me,” said Hayzlett. “I am honored to emcee the O2 breathe Gala and look forward to spreading awareness of the work of PHA with Rolonda Watts in the new Celebrity Crowdfunding Magazine.” In addition to receiving one of the evening’s top honors, YouTube sensation Temtchine will provide the event’s musical highlight through a special live performance.
About the Honorees:
On March 4, 2013, Ms. Temtchine was rushed to the emergency room with congestive right-heart failure. After being misdiagnosed for five years by some of the most respected and acclaimed medical practitioners and institutions in New York City, she was finally diagnosed with severe pulmonary hypertension (PH). Just over a year after receiving the devastating diagnosis, Chloe debuted her new song, “Be Brave,” to a sold-out crowd. The song is about making the choice to live. But, it’s more than words. It’s a lifestyle. “Be Brave,” available on iTunes, has since been adopted by the PH community as their anthem, and pharmaceutical companies have shipped in excess of 20K copies to their clients. Chloe donates fifty percent of the proceeds to PHA to support their mission of finding a cure.
Mr. Azimi is a Managing Partner and co-founder of Vanterra Capital LLC, global private equity firm that manages assets for a diverse investor base of ultra-high net worth partners and leading institutions. Mr. Azimi has over seventeen years of global private equity investment experience. Mr. Azimi received his B.S. with dual concentrations in Finance and International Business with Honors from the McIntire School of Commerce at the University of Virginia. He earned his MBA as a Beta Gamma Sigma graduate from Columbia Business School. Mr. Azimi currently serves as a board member for Vanterra TEM Capital, Cressey & Company Healthcare Fund, Mclarty Capital Partners SBIC, BTG Pactual Brazil Investment Fund, Jacob Ballas India Fund, and Vantem Composite Technologies LLC. Mr. Azimi is also a term member for the Council of Foreign Relations. He will be honored with the first annual O2 breathe Award for his work with the Pulmonary Hypertension Association.
Evelyn M. Horn, MD
Dr. Horn is Professor of Clinical Medicine and Director of the Advanced Heart Failure, Mechanical Circulatory Support and Pulmonary Vascular Disease Programs at the Perkin Heart Failure Center at Weill Cornell Medical Center, NY and an adjunct Professor at Columbia University. She has expertise in heart failure, primary and secondary pulmonary hypertension, ventricular and vascular remodeling in heart failure and pulmonary hypertension, ventricular assist devices in heart failure, and cardiac transplant. Prior to this, she has served as Director of Clinical Services for the Heart Failure Research Center; Director of Pulmonary Vascular Disease at the Center for Advanced Cardiac Care, Director of Cardiac OB High Risk as well as Co-Director of the Pediatric/Medicine Pulmonary Hypertension Center at Columbia University Medical Center/NY Presbyterian Hospital where she previously was for 22 years prior to her recruitment to Weill Cornell in November 2007. Dr. Horn will receive the first annual Robyn Barst Award in honor of the pioneer and colleague who, for two-and-a-half decades, established herself as a leader in the field.
About the Event
Thursday, November 6, 2014
The Lighthouse on Pier 61 at Chelsea Piers
7:30 p.m. Cocktails and Step and Repeat photos
8:30 p.m. – 11:00 p.m. Dinner, awards and a special performance by Ms. Temtchine
For tickets and additional information, go to http://www.O2breathe.org/nycgala or call 646-568-2068.